mothertobaby tirzepatide breastfeeding fact sheet While Breastfeeding: Safety & Guidelines Fact Sheets - Pregnancy and

FDA-approved for weight loss

They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition

True allergic reactions are rare but possible

2017;5(1):e000341

Follow the peptide storage guide principles and the specific dating on your vial

What the label actually says The Mounjaro and Zepbound prescribing information states: "Available data with tirzepatide use in pregnant women are insufficient to evaluate for a drug-related risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes." The label then references animal studies: "Based on animal reproduction studies, there may be risks to the fetus from exposure to tirzepatide during pregnancy." And the recommendation: "Advise pregnant women of the potential risk to a fetus